Litcius/Paper detail

Opioid Receptor μ-1 and Ketamine Effects in a Suicidal Depression Trial

Michael F. Grunebaum, Hanga Galfalvy, Jun Liu, Yung‐yu Huang, Stephen Marcott, Ainsley K. Burke, J. John Mann

2020Journal of Clinical Psychopharmacology13 citationsDOIOpen Access PDF

Abstract

Grunebaum, Michael F. MD; Galfalvy, Hanga C. PhD; Liu, Jun MPH; Huang, Yung-yu MS; Marcott, Stephen BS; Burke, Ainsley K. PhD; Mann, J. John MDAuthor Information

Topics & Concepts

KetamineDepression (economics)OpioidPsychologyPsychiatrySuicidal ideationMedicinePsychotherapistPoison controlSuicide preventionReceptorInternal medicineMedical emergencyMacroeconomicsEconomicsTreatment of Major DepressionTryptophan and brain disordersPain Mechanisms and Treatments
Opioid Receptor μ-1 and Ketamine Effects in a Suicidal Depression Trial | Litcius